ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 529,65
0,35%
Dow Jones
38 589,16
0,00%
DAX
18 028,49
0,04%
Brent Oil
82,595
0,57%
Bitcoin
65 550,41
-1,63%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. PAVmed Inc (PAVM)

  7. PAVmed Inc (PAVM) Actualités

PAVM

PAVmed (PAVM)

PAVmed Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:PAVM
DateHeureSourceTitreSymboleSociété
13/06/202413h58PR Newswire (US)PAVmed Subsidiary, Veris Health, Announces Launch of Pilot Program with The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research InstituteNASDAQ:PAVMPAVmed Inc
12/06/202414h05PR Newswire (US)4,000th Firefighter Undergoes Lucid Diagnostics' EsoGuard® Esophageal Precancer TestingNASDAQ:PAVMPAVmed Inc
14/05/202402h43PR Newswire (US)PAVmed Provides Business Update and First Quarter 2024 Financial ResultsNASDAQ:PAVMPAVmed Inc
13/05/202414h00PR Newswire (US)Lucid Diagnostics Provides Business Update and First Quarter 2024 Financial ResultsNASDAQ:PAVMPAVmed Inc
09/05/202413h49PR Newswire (US)Legacy Sponge-on-a-String Esophageal Cell Collection Device Subject of Class II FDA RecallNASDAQ:PAVMPAVmed Inc
07/05/202413h39PR Newswire (US)Lucid Diagnostics Closes Series B / B-1 Preferred Stock Offering and Appoints Healthcare Industry Veteran Dennis Matheis to Board of DirectorsNASDAQ:PAVMPAVmed Inc
03/05/202414h35PR Newswire (US)PAVmed to Hold a Business Update Conference Call and Webcast on May 14, 2024NASDAQ:PAVMPAVmed Inc
02/05/202414h35PR Newswire (US)Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on May 13, 2024NASDAQ:PAVMPAVmed Inc
02/05/202413h49PR Newswire (US)Lucid Diagnostics Announces Peer-Reviewed Publication of Positive Data from National Cancer Institute-Sponsored, Prospective, Multicenter Clinical Validation Study of EsoGuard® Esophageal Precancer TestingNASDAQ:PAVMPAVmed Inc
30/04/202413h35PR Newswire (US)PAVmed Subsidiary, Veris Health, Signs Memorandum of Understanding with The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research InstituteNASDAQ:PAVMPAVmed Inc
29/04/202414h47PR Newswire (US)Lucid Diagnostics Partners with the Esophageal Cancer Action Network (ECAN) to Highlight Esophageal Cancer Awareness MonthNASDAQ:PAVMPAVmed Inc
08/04/202414h30PR Newswire (US)Lucid Diagnostics to Participate in Fireside Chat at the 23rd Annual Needham Virtual Healthcare ConferenceNASDAQ:PAVMPAVmed Inc
27/03/202400h32PR Newswire (US)PAVmed Provides Business Update and Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:PAVMPAVmed Inc
21/03/202414h30PR Newswire (US)Lucid Diagnostics Announces Positive Data from the First Prospective Clinical Validation Study of EsoGuard® Esophageal Precancer Testing in a Screening PopulationNASDAQ:PAVMPAVmed Inc
21/03/202413h30PR Newswire (US)PAVmed Launches Incubator to Advance Existing Pipeline Technologies including PortIO, EsoCure and CarpXNASDAQ:PAVMPAVmed Inc
20/03/202413h30PR Newswire (US)Lucid Diagnostics Announces Multiple Presentations at the Upcoming Digestive Disease Week (DDW) 2024 ConferenceNASDAQ:PAVMPAVmed Inc
13/03/202413h30PR Newswire (US)PAVmed to Hold a Business Update Conference Call and Webcast on March 27, 2024NASDAQ:PAVMPAVmed Inc
12/03/202413h30PR Newswire (US)Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on March 26, 2024NASDAQ:PAVMPAVmed Inc
08/03/202422h30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PAVMPAVmed Inc
23/02/202422h49Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PAVMPAVmed Inc
20/02/202422h45Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:PAVMPAVmed Inc
16/02/202423h00PR Newswire (US)Lucid Diagnostics Provides Update Regarding World Trade Center Health ProgramNASDAQ:PAVMPAVmed Inc
15/02/202413h45PR Newswire (US)Lucid Diagnostics Chairman & CEO, Dr. Lishan Aklog, Highlights EsoCheck® Esophageal Cell Collection Device during Congressional TestimonyNASDAQ:PAVMPAVmed Inc
14/02/202421h38Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:PAVMPAVmed Inc
08/02/202413h45PR Newswire (US)Lucid Diagnostics Executes Contract to Provide EsoGuard® Esophageal Precancer Testing as a Covered Benefit for 9/11 Responders and SurvivorsNASDAQ:PAVMPAVmed Inc
06/02/202423h17Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:PAVMPAVmed Inc
12/12/202314h30PR Newswire (US)Lucid Diagnostics Announces Peer-Reviewed Publication of Positive Results from Three Clinical Utility StudiesNASDAQ:PAVMPAVmed Inc
11/12/202315h00PR Newswire (US)PAVmed Provides Additional Details for Upcoming Stock Dividend to ShareholdersNASDAQ:PAVMPAVmed Inc
04/12/202322h20PR Newswire (US)PAVmed Announces Dividend of Lucid Diagnostics Common Stock and Reverse Stock SplitNASDAQ:PAVMPAVmed Inc
16/11/202315h00PR Newswire (US)Lucid Diagnostics Strengthens and Expands Market Access and Direct Contracting EffortsNASDAQ:PAVMPAVmed Inc
 Showing the most relevant articles for your search:NASDAQ:PAVM

Dernières Valeurs Consultées

EU
CS
Axa
EU
ORA
Orange
NASDAQ
NVDA
NVIDIA
EU
VK
Vallourec
EU
RI
Pernod Ricard
EU
BNP
BNP Paribas
EU
BEL20
Bel 20
NASDAQ
AAPL
Apple
EU
SGO
Cie de SaintGobain
EU
HO
Thales
EU
MC
Lvmh Moet Hennessy Louis...
EU
CAP
Capgemini
NYSE
JPM
JP Morgan Chase
EU
LR
Legrand
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés